Quantum Dot Based Luminescent Nanoprobes for Sigma-2 Receptor Imaging

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Oncology

Background:

• The sigma-2 receptor is a crucial target for tumor diagnosis and therapy.
• Developing effective fluorescent probes for tumor imaging is essential for cancer management.
• Existing organic fluorescent molecules have limitations in tumor cell contrast and therapeutic applications.

Purpose of the Study:

• To develop novel hybrid organic-inorganic nanostructures for targeted tumor imaging.
• To combine the fluorescent properties of quantum dots with the targeting capabilities of sigma-2 receptor ligands.
• To create advanced fluorescent probes for selective sigma-2 receptor imaging and potential theranostic applications.

Main Methods:

• Synthesized hybrid nanostructures: quantum dots coated with silica shells (QD@SiO2 NPs).
• Functionalized NPs with two sigma-2 receptor selective ligands: MLP66 and TA6.
• Evaluated NP internalization and sigma-2 receptor affinity using flow cytometry and confocal fluorescence microscopy on MCF7 cells.

Main Results:

• Successfully developed QD@SiO2 NPs functionalized with MLP66 and TA6 ligands.
• Demonstrated internalization of functionalized NPs into MCF7 cells overexpressing sigma-2 receptors.
• Validated the sigma-2 receptor targeting ability of the nanoprobes through cellular experiments.

Conclusions:

• The developed QD-based nanoprobes exhibit selective targeting of sigma-2 receptors.
• These nanoprobes show significant potential as in vitro imaging agents for cancer diagnosis.
• The findings support the future impact of these nanoprobes in theranostic applications for cancer treatment.